New Launches and Pipeline Investments Support Alcon's Market Leadership and Strong Fundamentals
Alcon is one of the leading visioncare companies in the world and operates in two segments: vision care and surgical.
Alcon Inc ALC
Bulls Say, Bears Say
Bulls
Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products that should lead to market outperformance.
Bears
A misstep in commercial execution for new product launches could hinder Alcon's market position and weigh down future growth rates across business units.
News
-
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
-
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
-
FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
-
Alcon Gets FDA Approval for Brytly Eye Drops
-
FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
-
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
-
Alcon Prices EUR 500 Million Senior Notes Offering
-
Alcon Prices EUR 500 Million Senior Notes Offering
Trading Information
- Previous Close Price
- CHF 57.84
- Day Range
- CHF 57.32–57.94
- 52-Week Range
- CHF 47.80–68.34
- Bid/Ask
- CHF 0.00 / CHF 58.00
- Shares Outstanding
- 483.40M
- Market Cap
- CHF 28.01B
- Volume/Avg
- 875,401 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 34.47
- Price/Sales
- 3.30
- Dividend Yield (Trailing)
- 0.48%
- Dividend Yield (Forward)
- 0.48%
- Dividend Payment Schedule
- May
- Total Yield
- 3.07%
Company Profile
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Core
- Total Number of Employees
- 25,942
- Website
- https://www.alcon.com
Competitors
Valuation
|
Metric
|
ALC
|
COO
|
AFX
|
|---|---|---|---|
Price/Earnings (Normalized) | 34.47 | 13.29 | 23.14 |
Price/Book Value | 1.61 | 1.40 | 1.47 |
Price/Sales | 3.30 | 2.83 | 1.42 |
Price/Cash Flow | 13.91 | 12.66 | 12.62 |
Price/Earnings
ALC
COO
AFX
Financial Strength
|
Metric
|
ALC
|
COO
|
AFX
|
|---|---|---|---|
Quick Ratio | 1.12 | 0.51 | 1.40 |
Current Ratio | 2.09 | 1.22 | 2.34 |
Interest Coverage | 4.19 | 6.18 | 7.20 |
Quick Ratio
ALC
COO
AFX
Profitability
|
Metric
|
ALC
|
COO
|
AFX
|
|---|---|---|---|
Return on Assets (Normalized) | 5.09% | 7.25% | — |
Return on Equity (Normalized) | 7.28% | 10.89% | — |
Return on Invested Capital (Normalized) | 6.30% | 9.02% | — |
Return on Assets
ALC
COO
AFX
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|&b!@rb< | LOCK|^s@ | $160B | |||
| Becton Dickinson & Co
BDX
| LOCK|$@ | LOCK|%SQ> | $54B | |||
| ResMed Inc
RMD
| LOCK|h@$vh#%< | LOCK|>^TK | $36B | |||
| Alcon Inc
ALC
| LOCK|dwf#<T | LOCK|^?%qD | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|>njZyk | LOCK|Bk<r< | $30B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|?Q!Mrn! | LOCK|QR | $28B | |||
| Solventum Corp
SOLV
| LOCK|TbBZr# | LOCK|$%< | $15B | |||
| Baxter International Inc
BAX
| LOCK|%ln | LOCK|@Rvj> | $13B | |||
| The Cooper Companies Inc
COO
| LOCK|c@vW>C | LOCK|$!pg | $12B | |||
| Repligen Corp
RGEN
| LOCK|jGbRR^^ | LOCK|sh&< | $11B |
United States